Topical Calcineurin Inhibitors vs Topical Corticosteroids

Both treatments reduce skin inflammation, but they are not interchangeable in every situation. Corticosteroids are selected for their anti-inflammatory effect and come in different strengths. Calcineurin inhibitors modify local immune signalling without being a steroid and are often considered for delicate sites or repeated treatment when clinically suitable.

A calcineurin inhibitor may be considered for eczema or dermatitis affecting a sensitive area, especially when repeated steroid exposure is a concern. It can also be selected when inflammation returns in a site that needs a maintenance strategy. Brief warmth or stinging is possible after application. Avoid applying it to an unassessed infection, and seek advice if the rash changes character or spreads.

A topical corticosteroid may be chosen for a clear inflammatory flare when a clinician wants a predictable strength matched to the body site. The face, eyelids, skin folds, and genital skin generally need more cautious selection than thicker skin. Apply a thin layer for the prescribed duration; using more or continuing longer does not make the plan safer or more effective.

Calcineurin inhibitors may cause early burning, warmth, or itch, while corticosteroids may cause irritation and, with unsuitable strength or prolonged use, thinning, visible small vessels, or changes in skin texture. Neither should be used to mask a suspected infection without assessment. Keep the product away from eyes unless specifically prescribed there, wash hands after application, and report worsening pain, pus, crusting, or rapid spread.

A rash that is ring-shaped, blistering, crusted, painful, or rapidly spreading may not be a straightforward eczema flare. Contact dermatitis, fungal infection, scabies, psoriasis, and other conditions can resemble one another but require different treatment. If the diagnosis is uncertain or the rash fails to respond as expected, an examination is more useful than switching between anti-inflammatory creams.

The clinician weighs diagnosis, body site, flare intensity, age, previous response, infection risk, and how often symptoms recur. A corticosteroid may control an active flare, followed by a different plan for sensitive or repeatedly affected areas. A calcineurin inhibitor may be appropriate in selected cases, but it is not automatically safer for every rash. Discuss the intended duration and what improvement should look like. Read more about [Topical Calcineurin Inhibitors](/treatments/medical-dermatology/topical-calcineurin-inhibitors/) and [Topical Corticosteroids](/treatments/medical-dermatology/topical-corticosteroids/).